本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

15.28
+0.63004.30%
成交量:48.39萬
成交額:729.70萬
市值:18.13億
市盈率:-13.20
高:15.40
開:14.75
低:14.74
收:14.65
資料載入中...
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]